EssilorLuxottica to Acquire Optegra, Expanding Presence in European Ophthalmology Market

依视路陆逊梯卡将收购Optegra，扩大其在欧洲眼科市场的影响力

May 30, 2025

2025年5月30日

EssilorLuxottica has entered into an agreement with MidEuropa to acquire Optegra, a European ophthalmology provider operating in the UK, Czech Republic, Poland, Slovakia, and the Netherlands. The acquisition is part of EssilorLuxottica’s broader med-tech strategy and is expected to close in late 2025, pending regulatory approvals and customary closing conditions..

依视路陆逊梯卡已与MidEuropa达成协议，收购在英国、捷克、波兰、斯洛伐克和荷兰运营的欧洲眼科护理提供商Optegra。此次收购是依视路陆逊梯卡更广泛的医疗技术战略的一部分，预计将在2025年底完成，但需获得监管机构的批准并满足惯例的交割条件。

Optegra's Network and Clinical Services

奥普特格拉的网络与临床服务

Optegra, operating under the Optegra, Lexum, and Iris brands, manages a network of more than 70 eye hospitals and diagnostic facilities. The group offers a range of ophthalmic treatments, including:

奥普特格拉（Optegra）在奥普特格拉、列克瑟姆（Lexum）和艾瑞斯（Iris）品牌下运营，管理着一个由70多家眼科医院和诊断机构组成的网络。该集团提供一系列眼科治疗，包括：

• Cataract surgery

• 白内障手术

• Treatment for glaucoma and age-related macular degeneration (AMD)

• 青光眼和年龄相关性黄斑变性（AMD）的治疗

• Refractive lens exchange

• 屈光性晶状体置换

• Laser eye surgery

• 激光眼科手术

Its services are provided to both publicly reimbursed and private-pay patients. The organization also integrates AI technologies in pre- and post-operative care workflows.

其服务提供给公共报销和自费患者。该组织还在术前和术后护理工作流程中整合了人工智能技术。

Strategic Context for EssilorLuxottica

依视路陆逊梯卡的战略背景

This acquisition supports EssilorLuxottica’s strategy to expand into clinical eyecare, complementing its existing portfolio of products and services, which includes:

此次收购支持了EssilorLuxottica扩展到临床眼科护理的战略，与其现有的产品和服务组合相辅相成，其中包括：

• Eyewear and lenses

• 眼镜和镜片

• AI-driven diagnostic technologies

• 人工智能驱动的诊断技术

• Medical instruments

• 医疗器械

• Wearable and digital health solutions

• 可穿戴设备和数字健康解决方案

“With the acquisition of Optegra, we are stepping into a new frontier—one where comprehensive eyecare, advanced diagnostics, therapeutic interventions, and surgical treatments come together in one seamless platform,” said Francesco Milleri, Chairman and Chief Executive Officer of EssilorLuxottica, and Paul du Saillant, Deputy CEO..

“通过收购Optegra，我们正迈入一个新领域——在这个领域中，全面的眼科护理、先进的诊断、治疗干预和手术治疗将整合在一个无缝的平台上，”依视路陆逊梯卡集团董事长兼首席执行官弗朗切斯科·米勒里以及副首席执行官保罗·杜赛尔表示。

“Optegra and its experienced doctors will bring new medical capabilities to our Group, enabling us to address patients’ needs with the most advanced vision care technologies and treatments in one trusted system that will anchor our med-tech aspirations.”

“奥普特格拉及其经验丰富的医生将为我们的集团带来新的医疗能力，使我们能够通过最先进的视力护理技术和治疗手段，在一个值得信赖的体系中满足患者的需求，这一体系将支撑我们在医疗技术领域的雄心。”